Tokyo Cardiovascular Care Unit Network Scientific Committee, Tokyo, Japan; Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.
Tokyo Cardiovascular Care Unit Network Scientific Committee, Tokyo, Japan.
J Cardiol. 2023 Nov;82(5):356-362. doi: 10.1016/j.jjcc.2023.06.006. Epub 2023 Jun 19.
Hypoalbuminemia is common in critically ill patients and is associated with poor outcomes. However, the relationship between serum albumin levels and clinical outcomes in patients with takotsubo syndrome remains unclear. We examined the impact of hypoalbuminemia on in-hospital mortality in patients with takotsubo syndrome.
Using the multicenter registry of the Tokyo Cardiovascular Care Unit Network between January 2017 and December 2020, we identified 631 eligible patients with takotsubo syndrome (median age, 78 years; male proportion, 22 %) and documented serum albumin levels at admission, which were used to allocate patients to hypoalbuminemia (serum albumin <3.5 g/dL) or normal albumin (serum albumin ≥3.5 g/dL) groups. Patient characteristics and in-hospital mortality were compared between the groups.
Hypoalbuminemia was detected in 200 (32 %) patients at admission. The hypoalbuminemia group was older and had a higher proportion of men and preceding physical triggers than the normal albumin group. In-hospital all-cause mortality was greater in the hypoalbuminemia group than in the normal albumin group (9.5 % vs. 1.9 %, p < 0.001). Both cardiac (3.0 % vs. 0.5 %, p = 0.015) and non-cardiac (6.5 % vs. 1.4 %, p = 0.002) mortality was greater in the hypoalbuminemia group. In multivariable logistic regression analysis, hypoalbuminemia was independently associated with increased in-hospital mortality, even after adjusting for confounders, including age, sex, and triggering events (odds ratio, 3.23; 95 % confidence interval, 1.31-7.95; p = 0.011).
In patients with takotsubo syndrome, hypoalbuminemia is a common comorbidity and is associated with a substantial risk of in-hospital death. Close monitoring and comprehensive critical care are required in these patients.
低白蛋白血症在危重症患者中很常见,与不良预后相关。然而,在 Takotsubo 综合征患者中,血清白蛋白水平与临床结局的关系尚不清楚。我们研究了低白蛋白血症对 Takotsubo 综合征患者住院死亡率的影响。
利用 2017 年 1 月至 2020 年 12 月东京心血管护理单位网络的多中心登记处,我们纳入了 631 例符合条件的 Takotsubo 综合征患者(中位年龄 78 岁,男性比例 22%),并记录了入院时的血清白蛋白水平,据此将患者分为低白蛋白血症(血清白蛋白 <3.5g/dL)或正常白蛋白(血清白蛋白≥3.5g/dL)组。比较两组患者的特征和住院死亡率。
入院时,200 例(32%)患者存在低白蛋白血症。与正常白蛋白组相比,低白蛋白血症组年龄更大,男性比例和先前存在的躯体触发因素更高。低白蛋白血症组的住院全因死亡率高于正常白蛋白组(9.5%比 1.9%,p<0.001)。低白蛋白血症组的心脏(3.0%比 0.5%,p=0.015)和非心脏(6.5%比 1.4%,p=0.002)死亡率均更高。多变量逻辑回归分析显示,在校正年龄、性别和触发事件等混杂因素后,低白蛋白血症与住院死亡率增加独立相关(优势比,3.23;95%置信区间,1.31-7.95;p=0.011)。
在 Takotsubo 综合征患者中,低白蛋白血症是一种常见的合并症,与住院死亡风险显著增加相关。这些患者需要密切监测和综合重症监护。